Clinique and Allergan's joint venture hits physicians' shelves
The new range, Clinique Medical, has been formulated to complement procedures such as intense pulsed light therapy, chemical peels and microdermabrasion.
Pre- and post-treatment
According to the companies, the brand’s Optimizing Regimen Kit can help prepare the skin pre-treatment to make it more receptive to skin resurfacing, as well as aid skin recovery post-treatment.
“In-office skin resurfacing treatments achieve results in similar ways – layers of skin are removed, and through the healing process, new, healthier-looking skin emerges. During this time, skin has a unique set of needs,” explained dermatologist Vic Narurkar who led the clinical investigations of Clinique Medical.
With the new range, Clinique and Allergan have created something that they claim addresses these unique skin needs. As recent research suggests the popularity of non-surgical procedures is increasing, this new range is likely to stand the two companies in good stead.
Market for non-surgical procedures is growing
According to data from the American Society of Plastic Surgeons (ASPS), a total of 55 million cosmetics surgery procedures will be performed in 2015, four times as many as occurred in 2005.
And laser related procedures will be one of the drivers of this growth.
The two companies have chosen the physician distribution channel for the range, therefore providing perfect access to the target population.
Although Allergan has a number of products in the medical distribution channel, this is the first time Clinique has dealt with what has been described by analysts as a booming channel.
Sales within the channel remain small but are increasing at quite a pace, according to market research company Kline.
During 2007, sales of skin care products within the channel increased 16.5 per cent. This coupled with the increasing number of clinics offering such products, and the increasing diversity of practices getting involved, make the channel a good investment.
Commenting on the partnership between the two companies, that was announced earlier this year, Kline analyst Karen Doskow noted how for Clinique this was as much a long term brand extension strategy as it is an attempt to increase sales in the short term.
